Europe Insulin Delivery Devices Market – Industry Trends and Forecast to 2029

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

Europe Insulin Delivery Devices Market – Industry Trends and Forecast to 2029

  • Medical Devices
  • Upcoming Reports
  • Nov 2021
  • Europe
  • 150 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

Europe Insulin Delivery Devices Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2029
Diagramm Marktgröße (Basisjahr)
MILLIONEN USD
Diagramm Marktgröße (Prognosejahr)
USD 15,615.61 Million
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Medtronic
  • F Hoffmann-La Roche
  • Insulet Corporation
  • Tandem Diabetes Care
  • BD

Europe Insulin Delivery Devices Market, By Type (Insulin Syringes, Insulin Jet Injectors, Pen Needles, Insulin Pumps), Application (Type I Diabetes, Type II Diabetes), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics), End Use (Hospitals, Clinics, Homecare, Specialty Centers),  Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe) Industry Trends and Forecast to 2029.

Europe Insulin Delivery Devices Market Market Analysis and Insights of Insulin Delivery Devices Market

Insulin delivery devices market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses the market to grow at a CAGR of 6.20% in the above-mentioned forecast period.

Insulin is basically a vital part of the treatment plan for all patients suffering from Type 1 and Type 2 diabetes. The insulin delivery device is injected directly into the fatty tissues under the skin with the help of insulin pens, syringes, insulin pumps and jet injectors.

Rise in diabetic population , increase in diabetic related expenditure and collaboration of public and private sectors to meet diabetes needs as well as the favorable device insurance and reimbursement policies are the significant factors responsible for driving the growth of the insulin delivery devices market. In addition to this, the factors such as various favorable reimbursement environment and government support in selected countries along with the initiation of conferences, meetings, and congresses to spread awareness regarding insulin delivery devices also heighten the overall growth of the market. However, the poor reimbursement structure as well as the various issues related with the reuse of pen needles and infusion sets are the major factors that are estimated to hinder the market’s growth.

The rapid increase in research and development activities and rise in healthcare expenditure are expected to generate profitable opportunities for the market. On the other hand, the severe shortage of endocrinologists and strict government regulations and product approvals have the potential to challenge for the market’s growth.

This insulin delivery devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research insulin delivery devices market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Europe Insulin Delivery Devices Market Scope and Market Size

Insulin delivery devices market is segmented on the basis type, application, distribution channel and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the insulin delivery devices market is segmented into insulin syringes, insulin jet injectors, pen needles, and insulin pumps. The pen needles are sub-segmented into standard pen needles and safety pen needles. The pen needles are sub-segmented into external/tethered pumps and patch pumps.
  • On the basis of application, the insulin delivery devices market is segmented into type I diabetes and type II diabetes.
  • On the basis of distribution channel, the insulin delivery devices market is segmented into hospital pharmacy, retail pharmacy, online sales, and diabetes clinics.
  • On the basis of end use, the insulin delivery devices market is segmented into hospitals, clinics, homecare, and specialty centers.

Insulin Delivery Devices Market Country Level Analysis

Insulin delivery devices market is analyzed and market size insights and trends are provided by type, application, distribution channel and end-use as referenced above.

The countries covered in the insulin delivery devices market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey and Rest of Europe in Europe.

Germany dominates the insulin delivery devices market owing to the factors such as pervasiveness of numerous pharmaceuticals as well as for biotechnology companies. Growing prevalence of chronic diseases like obesity, or diabetes coupled with rising government initiatives to improve healthcare infrastructure will boost region market growth.

The country section of the insulin delivery devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Insulin delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for insulin delivery devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the insulin delivery devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Insulin Delivery Devices Market Share Analysis

Insulin delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Europe presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to insulin delivery devices market.

Some of the major players operating in the insulin delivery devices market report are Medtronic, F Hoffmann-La Roche Ltd., Insulet Corporation, Tandem Diabetes Care, Inc., BD, Novo Nordisk AS, Sanofi, Johnson & Johnson Private Limited ., Abbott, Terumo Corporation, Dexcom, Inc., AstraZeneca, BIOMEDICAL, INC., B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, WOCKHARDT, Biodel, Ypsomed AG, Copernicus, Biocon, West Pharmaceutical Services, Inc., InsuJet, SHL Medical AG, SOOIL Developments Co., Ltd, among others.


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The market is segmented based on , By Type (Insulin Syringes, Insulin Jet Injectors, Pen Needles, Insulin Pumps), Application (Type I Diabetes, Type II Diabetes), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics), End Use (Hospitals, Clinics, Homecare, Specialty Centers),  Country (Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe) Industry Trends and Forecast to 2029. .
The Europe Insulin Delivery Devices Market size was valued at USD 0.00 USD Million in 2022.
The Europe Insulin Delivery Devices Market is projected to grow at a CAGR of 6.2% during the forecast period of 2023 to 2029.
The major players operating in the market include Medtronic, F Hoffmann-La Roche , Insulet Corporation, Tandem Diabetes Care , BD, Novo Nordisk AS, Sanofi, Johnson & Johnson Private Limited, Abbott, Terumo Corporation, Dexcom , AstraZeneca, B. Braun Melsungen AG, Julphar, Eli Lily and Company, Biocon, among others -.